Are People in Their 30s in the UK Also Avoiding AstraZeneca? Authorities Say "Under Review"

AstraZeneca COVID-19 Vaccine [Image source=Yonhap News]

[Asia Economy Reporter Ryu Tae-min] The Telegraph reported on the 23rd (local time) that the UK is considering administering COVID-19 vaccines other than AstraZeneca to people in their 30s due to concerns about blood clots.

The UK's Joint Committee on Vaccination and Immunisation (JCVI) is reportedly considering whether a policy change is necessary before expanding vaccination to those under 40, according to The Telegraph. Previously, on the 7th, the committee recommended that people under 30 receive vaccines other than AstraZeneca due to the very rare side effect of cerebral blood clots. At that time, Professor Jonathan Van-Tam, England's Deputy Chief Medical Officer, stated that for people in their 30s, the benefits of vaccination outweigh the risks.

However, The Telegraph pointed out that this calculation might change as the incidence of blood clots has recently increased. According to new data from the UK's Medicines and Healthcare products Regulatory Agency (MHRA), the risk of serious blood clots has risen from 1 in 250,000 people to 1 in 126,600 people within two weeks.

The Financial Times also reported that scientific advisers to the UK government are divided on whether to recommend vaccines other than AstraZeneca for people in their 30s.

This content was produced with the assistance of AI translation services.